Featured
Pharma PR campaigns shortlisted for awards
The Golden Target Awards shortlist is out with a strong showing of pharma PR campaigns competing to take home a trophy across a number of categories
Leadership & People
Top GSK prize marks revolution in respiratory care
Researcher recognised for her work in determining why some people suffer life-threatening illnesses from respiratory viruses, potentially transforming the way clinicians predict and manage severe respiratory illness.
Regulatory & Reimbursement
PBAC July meeting winners and losers
Almost three quarters of the new PBS listing submissions considered at the PBAC’s July meeting were given the green light, however many highly anticipated drugs have been delivered a blow
Regulatory & Reimbursement
New antibiotic arrives in Australia
Last week the TGA approved a new antibiotic along with a new strength of a lung cancer drug plus generics, and OTCs
Featured
PBAC says no to higher price for blockbuster
Company 'disappointed' after the PBAC knocked back a revised submission for the only TGA-approved biologic for uncontrolled severe atopic dermatitis in children under 12 over due to price
Jobs
Latest
Who's got a new job at an old company?
Job movements continue across industry and it's not always for somewhere new - with two industry executives returning to companies where they've worked before
Regulation & Legal
TGA dishes five-figure prescription drug fine
The Head of the TGA has threatened continued "strong compliance and enforcement action" after the Regulator issued its second significant fine in just over a month
Industry & Companies
'Rare' uptick in pharma's corporate reputation
Rare disease patient groups have picked their favourite pharma with industry's overall reputation rising to levels not seen for five years - but companies still have plenty to improve on
Leadership & People
Company bumps up Aussie Leadership Team
The appointment of two experienced industry executives to major roles underlines this pharma's "commitment to investing in world-class talent"
Industry & Companies
Aussie GMs unpack pricing pain points
Even with solid Phase 3 results showing a drug has a large benefit to patients, pharmas may hold off launching a drug in Australia over pricing
Leadership & People
Digital platform expands Senior Leadership team
Two new senior roles have been created, filled by an internal promotion and external hire, as the company expands its platform across Asia Pacific
Industry & Companies
Whose share price almost tripled overnight?
New trial results could redefine how cancer patients are treated with two companies experiencing a massive boost in share price and market cap, with one pharma seeing its stock almost triple in value
Industry & Companies
Aussie company on track to bank its first billion
Australia's largest radiopharma is determined that it's just getting started, increasing R&D spend twice as fast as revenue
Regulation & Legal
Black market booms for future blockbuster
This drug is still months off being filed for approval but there's already a booming black market with the Big Pharma that developed it taking a tough legal stand
- Other News How many of the best US drugs have reached Australia?
- Industry & Companies Pharma a bright spot in CSL's "reset" year
- Regulatory & Reimbursement Blockbuster earnings nosedive by 80%
- Other News The hidden $1.2B cost of two diseases
- Industry & Companies NEXT Summit in full swing in Sydney
- Regulatory & Reimbursement Swedish pharma launches first drug
- Jobs & Workplace Big Pharma on Aussie hiring spree
- Regulation & Legal First win for J&J over alleged ineffective medicine
- Regulatory & Reimbursement 17 drugs vie for September PBS listing
- Industry & Companies What headwinds? Companies notch double-digit growth
